Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Carisma Therapeutics received early financing of $3.9M on 2018-04-17.
| Series | Round size | Date |
|---|---|---|
| Debt Financing | $3.9M | 04/2018 |
| Series A | $53M | 06/2018 |
| Series A | $6M | 08/2019 |
| Series B | $47M | 01/2021 |
| Series B | $12M | 03/2021 |
| Investors | Security type |
|---|---|
| Penn Medicine, University of Pennsylvania Health System | Series A |
| Agent Capital | Series A |
| HealthCap | Series A |
| Grazia Equity | Series A |
| MRL Ventures Fund LLC | Series A |
| TPG Biotech | Series A |
| AbbVie Biotech Ventures Inc | Series A |
| Penn Medicine Co-Investment Program | Series A |
| WELLINGTON PARTNERS | Series A |
| IP Group PLC | Series A |
| HealthCap | Series A |
| AbbVie Biotech Ventures Inc | Series A |
| Livzon Pharmaceutical Group | Series B |
| Agent Capital | Series B |
| SymBiosis LLC | Series B |
| HealthCap | Series B |
| MRL Ventures Fund LLC | Series B |
| Solasta Ventures | Series B |
| TPG Biotech | Series B |
| AbbVie Biotech Ventures Inc | Series B |
| WELLINGTON PARTNERS | Series B |
| IP Group PLC | Series B |
| Livzon Pharmaceutical Group | Series B |
| Agent Capital | Series B |
| SymBiosis LLC | Series B |
| HealthCap | Series B |
| MRL Ventures Fund LLC | Series B |
| Solasta Ventures | Series B |
| TPG Biotech | Series B |
| Penn Medicine Co-Investment Program | Series B |
| AbbVie Biotech Ventures Inc | Series B |
| WELLINGTON PARTNERS | Series B |
| 4BIO Capital | Series B |
| IP Group PLC | Series B |
Zippia gives an in-depth look into the details of Carisma Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Carisma Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Carisma Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Carisma Therapeutics. The data presented on this page does not represent the view of Carisma Therapeutics and its employees or that of Zippia.
Carisma Therapeutics may also be known as or be related to CARISMA Therapeutics, CARISMA Therapeutics Inc., Carisma Therapeutics, Carisma Therapeutics Inc and Carisma Therapeutics, Inc.